NCT06499350 2026-03-10
A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase 1/2 Recruiting
FindCure Biosciences (ZhongShan) Co., Ltd.
Genmab
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
The First Affiliated Hospital of Nanchang University
Shanghai Junshi Bioscience Co., Ltd.
Mabwell (Shanghai) Bioscience Co., Ltd.
Hutchmed